NEWS!!!
BETHESDA, Md., May 11, 2007 (BUSINESS WIRE) -- Healthnostics, Inc. (Pink
Sheets:HNSO), a medical and biotechnology analytics company, is pleased to
provide the following update report regarding the Company's development and
progress.
Special Stock Distribution
The Special Stock Distribution previously announced for shareholders of record
as of March 12, 2007 is proceeding for completion in May. The Company first had
to finish the share structure change in which a concurrent reverse split and a
forward split of Healthnostics stock was undertaken in order to cancel
shareholder accounts holding less than 100 shares. These were paid in cash equal
to $.026 per share. Now that this process has been completed by our transfer
agent, the Special Stock Distribution can proceed.
MedBioWeb Corp.
MedBioWeb's newly redesigned medical and biotechnology professional portal
MedBioWorld.com has drawn praise from its users and has an increasing user base.
New advertising and partner affiliate programs are underway. MedBioNews
e-newsletter subscribers have substantially increased and there are major new
sponsorship and advertising opportunities that have been produced by The
Fieldstone Hill Group.
Healthnostics' MedBioWeb Corp. subsidiary continues to be in the registration
process with the Securities and Exchange Commission. Previously, Healthnostics
announced that the Company had filed a registration statement to spin-off
MedBioWeb Corp., into a new, fully reporting company. Please Note: This spin-off
equates to 100% ownership of MedBioWeb by Healthnostics shareholders. Further,
as an added benefit to Healthnostics shareholders, all MedBioWeb shares will be
registered and free-trading, regardless of whether shares of Healthnostics owned
are free-trading or bear a restrictive legend.
Clinical Software Systems
MedGuardian, which addresses critical quality improvement issues facing
hospitals today, continues to be successfully marketed to hospital associations,
government and private sector hospitals generating new and viable future sales
opportunities. Healthnostics' target market for MedGuardian is the 4,200 small
to medium sized acute care hospitals that constitute the majority of hospitals
in the U.S.
Strategy
The Company's strategy is to leverage, build or acquire compatible healthcare
technologies that will create valuable business offerings for us in the
healthcare and biotechnology information technology market.
"We are executing on our corporate plan through incubator spin-off initiatives
such as MedBioWeb, developing continuous quality improvement opportunities with
important hospital prospects, and building content and adding revenue
initiatives with our major medical and biotechnology portals," said Alan Grofe,
President.
For further information please visit Healthnostics
http://www.healthnostics.com,
MedBioWorld
http://www.medbioworld.com, and FamilyMedicalNet
http://www.familymedicalnet.com.
This press release may contain certain statements that are not descriptions of
historical information, but are forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of
1934. These forward-looking statements refer to matters that involve risks and
uncertainties. Such statements reflect management's current views and are based
on certain assumptions. Actual results could differ materially from the
assumptions currently anticipated.
SOURCE: Healthnostics, Inc.
CONTACT: SmallCapVoice.comStuart T. Smith, 512-267-2430F. 512-267-2530SSmith@SmallCapVoice.comwww.SmallCapVoice.comorfor Healthnostics, Inc.Jason Pollack, 561-731-2215
Copyright Business Wire 2007
Logged
Male
